FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
1-Year Return
23.12%
This Quarter Return
+13.51%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$14.1B
AUM Growth
+$1.66B
(+13%)
Cap. Flow
+$700M
Cap. Flow
% of AUM
4.96%
Top 10 Holdings %
Top 10 Hldgs %
32.58%
Holding
150
New
30
Increased
52
Reduced
23
Closed
23
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$498M |
| 2 |
Boston Scientific
BSX
|
$316M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$208M |
| 4 |
Hilton Worldwide
HLT
|
$132M |
| 5 |
New York Times
NYT
|
$127M |
Top Sells
| 1 |
IAC Inc
IAC
|
$456M |
| 2 |
WUBA
58.COM INC
WUBA
|
$268M |
| 3 |
Salesforce
CRM
|
$208M |
| 4 |
Qiagen
QGEN
|
$123M |
| 5 |
CZR
Caesars Entertainment Corporation
CZR
|
$97.2M |
Sector Composition
| 1 | Healthcare | 41.8% |
| 2 | Communication Services | 18.01% |
| 3 | Technology | 8.41% |
| 4 | Financials | 7.57% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Krystal Biotech
KRYS
$4.35B
| $20.4M | 0.14% |
475,000
+25,000
| +6% | +$1.08M |
|
|
ADAP
77
Adaptimmune Therapeutics
ADAP
$10.9M
| $20.1M | 0.14% |
2,515,762
+15,762
| +0.6% | +$126K |
|
|
ZEAL
78
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $19.2M | 0.13% |
505,000
+5,000
| +1% | +$190K |
|
79
Arrowhead Research
ARWR
$4.02B
| $18.2M | 0.13% |
423,600
-376,400
| -47% | -$16.2M |
|
80
Pliant Therapeutics
PLRX
$114M
| $17.3M | 0.12% |
764,262
-86,539
| -10% | -$1.96M |
|
|
DCPH
81
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $16.9M | 0.12% |
330,000
-385,000
| -54% | -$19.8M |
|
82
uniQure
QURE
$985M
| $16.6M | 0.11% |
450,000
+150,000
| +50% | +$5.52M |
|
83
Adverum Biotechnologies
ADVM
$73.9M
| $15.5M | 0.11% |
+150,000
| New | +$15.5M |
|
|
RC
84
Ready Capital
RC
$705M
| $15.1M | 0.1% |
1,350,226
| – | – |
|
85
Aurinia Pharmaceuticals
AUPH
$1.63B
| $14.7M | 0.1% |
+1,000,000
| New | +$14.7M |
|
|
DMTK
86
DELISTED
DermTech, Inc. Common Stock
DMTK
| $14.6M | 0.1% |
1,219,999
+1,025,324
| +527% | +$12.3M |
|
|
TECX
87
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $13.7M | 0.09% |
87,500
-43,750
| -33% | -$6.84M |
|
|
CMPS
88
Compass Pathways
CMPS
$493M
| $12.7M | 0.09% |
+362,940
| New | +$12.7M |
|
|
NAV
89
DELISTED
Navistar International
NAV
| $12M | 0.08% |
+276,600
| New | +$12M |
|
|
ATTO
90
DELISTED
Atento S.A.
ATTO
| $12M | 0.08% |
2,230,357
| – | – |
|
|
HZNP
91
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.7M | 0.08% |
+150,000
| New | +$11.7M |
|
92
Willis Towers Watson
WTW
$32.1B
| $10.4M | 0.07% |
+50,000
| New | +$10.4M |
|
93
Arcus Biosciences
RCUS
$1.3B
| $9.43M | 0.07% |
550,000
-450,000
| -45% | -$7.71M |
|
94
Liquidia Corp
LQDA
$2.48B
| $9.18M | 0.06% |
1,865,350
+15,350
| +0.8% | +$75.5K |
|
95
Protara Therapeutics
TARA
$122M
| $7.15M | 0.05% |
+425,000
| New | +$7.15M |
|
|
INBX
96
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $7.11M | 0.05% |
+395,000
| New | +$7.11M |
|
|
ALBO
97
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $6.67M | 0.05% |
+200,000
| New | +$6.67M |
|
|
ALPN
98
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $6.52M | 0.05% |
+741,290
| New | +$6.52M |
|
|
IVA
99
Inventiva
IVA
$775M
| $6.23M | 0.04% |
+527,870
| New | +$6.23M |
|
100
Savara
SVRA
$643M
| $4.85M | 0.03% |
4,452,086
-18,878
| -0.4% | -$20.6K |
|